Leap Therapeutics, Inc. Common Stock (LPTX)
Leap Therapeutics, Inc. (LPTX) is a biotechnology company focused on developing innovative immuno-oncology therapies. The company aims to create targeted treatments that enhance the body's immune response against cancer by identifying and developing novel biologic agents. Based in the United States, Leap Therapeutics is engaged in advancing therapies through research and clinical trials to address unmet needs in cancer treatment.
Company News
Leap Therapeutics reported a wider net loss in Q2 2025, initiated a strategic alternatives process, and reduced workforce by 75% while continuing clinical trials for cancer therapies.
The metastatic colorectal cancer pipeline is rapidly expanding, with over 150 pharmaceutical companies developing 180+ pipeline drugs. Novel therapies, including small molecules, antibodies, and tumor microenvironment modulators, are gaining traction and could reshape the treatment landscape.
Leap Therapeutics (LPTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology. FLJ Group shares jumped 96.4% to $0.2123 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Versus Systems Inc. (NASDAQ: VS) shares ju...
Penny stocks under $1 to watch this week. The post 3 Hot Penny Stocks To Watch Under $1, Time To Buy? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
